NO912670L - Nye derivater av 1-difenylmetyl-piperazin, deres fremstilling og anvendelse som medikament. - Google Patents

Nye derivater av 1-difenylmetyl-piperazin, deres fremstilling og anvendelse som medikament.

Info

Publication number
NO912670L
NO912670L NO91912670A NO912670A NO912670L NO 912670 L NO912670 L NO 912670L NO 91912670 A NO91912670 A NO 91912670A NO 912670 A NO912670 A NO 912670A NO 912670 L NO912670 L NO 912670L
Authority
NO
Norway
Prior art keywords
medicine
preparation
new derivatives
diphenylmethyl piperazine
diphenylmethyl
Prior art date
Application number
NO91912670A
Other languages
English (en)
Norwegian (no)
Other versions
NO912670D0 (no
Inventor
Maria Rosa Cuberes-Altisent
Jordi Frigola-Constansa
Juan Pares-Corominas
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of NO912670D0 publication Critical patent/NO912670D0/no
Publication of NO912670L publication Critical patent/NO912670L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
NO91912670A 1990-07-26 1991-07-08 Nye derivater av 1-difenylmetyl-piperazin, deres fremstilling og anvendelse som medikament. NO912670L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9009562A FR2665160A1 (fr) 1990-07-26 1990-07-26 Nouveaux derives de 1-diphenylmethylpiperazine, leur preparation et leur application en tant que medicaments.

Publications (2)

Publication Number Publication Date
NO912670D0 NO912670D0 (no) 1991-07-08
NO912670L true NO912670L (no) 1992-01-27

Family

ID=9399130

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91912670A NO912670L (no) 1990-07-26 1991-07-08 Nye derivater av 1-difenylmetyl-piperazin, deres fremstilling og anvendelse som medikament.

Country Status (17)

Country Link
US (1) US5166205A (cs)
EP (1) EP0468885A1 (cs)
JP (1) JPH04234359A (cs)
KR (1) KR920002581A (cs)
CN (1) CN1058397A (cs)
AU (1) AU638856B2 (cs)
CA (1) CA2047879A1 (cs)
CS (1) CS235091A3 (cs)
ES (1) ES2043515B1 (cs)
FR (1) FR2665160A1 (cs)
HU (1) HUT58319A (cs)
MX (1) MX9100378A (cs)
NO (1) NO912670L (cs)
NZ (1) NZ239105A (cs)
PL (1) PL291246A1 (cs)
PT (1) PT98408A (cs)
ZA (1) ZA915838B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH31566A (en) * 1990-10-10 1998-11-03 Schering Corp Pyridine and pyridine n-oxide derivatives for diaryl methyl piperidines or piperazines and compositions and methods of use thereof.
CA2132528C (en) * 1992-03-23 2004-06-08 Gerard Frans Maria Jan Cauwenbergh Agent for use as an anti-irritant
CA2132848A1 (en) * 1992-03-27 1993-10-14 Richard Friary Unabridged bis-aryl carbinol derivatives, compositions and methods of use
US5741800A (en) * 1993-06-22 1998-04-21 Knoll Aktiengesellachaft Azolyl-cyclic amine derivates with immunomodulatory activity
GB9312806D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
JP3338913B2 (ja) * 1993-06-29 2002-10-28 大鵬薬品工業株式会社 テトラゾール誘導体
USH2007H1 (en) 1996-01-19 2001-12-04 Fmc Corporation Insecticidal N-heterocyclylalkyl-or N-[(polycyclyl)alkyl]-N′substituted piperazines
MXPA03002446A (es) * 2000-09-20 2003-06-19 Schering Corp Imidazoles substituidos como agonistas o antagonistas duales h1 y h3 de histamina.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR58146E (fr) * 1948-05-03 1953-09-21 Dispositif pour le soutènement des mines, et en particulier des galeries
GB1184714A (en) * 1965-12-16 1970-03-18 Science Union & Cie Di- and Tri-Phenylpropyl Piperazine Derivatives
US3491098A (en) * 1967-05-29 1970-01-20 Sterling Drug Inc 1-((imidazolyl)-lower-alkyl)-4-substituted-piperazines
US4377578A (en) * 1976-12-21 1983-03-22 Janssen Pharmaceutica, N.V. Piperazine derivatives
US4338453A (en) * 1980-09-17 1982-07-06 The Upjohn Company Aminoalkyl-1,2,4-triazoles
FI75816C (fi) * 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
FR2601366B1 (fr) * 1986-07-10 1988-11-25 Andre Buzas Derives de la benzhydryloxyethyl-piperazine, procedes d'obtention et de compositions pharmaceutiques les contenant.
US5043447A (en) * 1987-04-24 1991-08-27 Syntex Pharmaceuticals, Ltd. Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
GB8716313D0 (en) * 1987-07-10 1987-08-19 Janssen Pharmaceutica Nv 2-(heterocyclylalkyl)imidazopyridines
JPH02124871A (ja) * 1988-07-27 1990-05-14 Dainippon Pharmaceut Co Ltd １位が置換された複素環式カルボン酸アミド誘導体
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
GB9021535D0 (en) * 1990-10-03 1990-11-14 Wyeth John & Brother Ltd Piperazine derivatives

Also Published As

Publication number Publication date
JPH04234359A (ja) 1992-08-24
ES2043515B1 (es) 1994-06-16
US5166205A (en) 1992-11-24
NZ239105A (en) 1993-09-27
KR920002581A (ko) 1992-02-28
HU912517D0 (en) 1992-01-28
CN1058397A (zh) 1992-02-05
MX9100378A (es) 1992-02-28
AU638856B2 (en) 1993-07-08
FR2665160A1 (fr) 1992-01-31
CA2047879A1 (fr) 1992-01-27
PT98408A (pt) 1992-06-30
EP0468885A1 (fr) 1992-01-29
NO912670D0 (no) 1991-07-08
AU8127991A (en) 1992-02-06
PL291246A1 (en) 1992-03-09
ZA915838B (en) 1992-04-29
ES2043515A1 (es) 1993-12-16
HUT58319A (en) 1992-02-28
CS235091A3 (en) 1992-05-13

Similar Documents

Publication Publication Date Title
NO874632D0 (no) Cyclodextrinclathrater av carbacyclinderivater og deres anvendelse som legemiddel.
NO934146D0 (no) Nye derivater av tiopyranopyrrol, deres fremstilling og farmas!ytiske preparater inneholdende forbindelsene
DK267489A (da) 1-deoxy-nojirimycin-derivater, deres fremstilling og anvendelse som laegemidler
NO924650D0 (no) Dialkoksy-pyridinyl-benzimidazolderivater, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse
NO934723L (no) Nye derivater av taksolanaloger, deres fremstilling og preparater inneholdende derivatene
DK381985D0 (da) 3-pyridylforbindelser, deres fremstilling og anvendelse som laegemiddel
DK143284A (da) Thiazolinderivater, deres fremstilling og anvendelse som laegemiddel
NO880473L (no) Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner og deres anvendelse som legemiddel.
DK168786D0 (da) Hidtil ukendte dopaminderivater, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
DK232689A (da) Substituerede 3-(n-heterocyclyl)-2,6-daiminopyridiner og -n-oxider, deres fremstilling og anvendelse som laegemiddel
DK219685D0 (da) Heterocycliske forbindelser, deres fremstilling og anvendelse som laegemidler
DK166590D0 (da) Substituerede allylaminderivater, deres fremstilling og anvendelse som laegemidler
NO912670D0 (no) Nye derivater av 1-difenylmetyl-piperazin, deres fremstilling og anvendelse som medikament.
DK627684D0 (da) 1,4-naphthoquinolinderivater, deres fremstilling og anvendelse som laegemiddel
DK619989A (da) Dipeptidderivater, deres fremstilling og anvendelse som laegemidler
DK648389A (da) Anthracylin-derivater, deres fremstilling og anvendelse som laegemidler
DK42888D0 (da) Arylthiadiazolylsulfonamider og derivater deraf, deres fremstilling og anvendelse som laegemiddel
NO803551L (no) Substituerte 2-amino-3,4-dihydropyridinderivater, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel
NO911465D0 (no) Fremgangsmaate for fremstilling av 4-(3-(4-oksotiazoldinyl))-butynylaminer og deres anvendelse som medikamenter.
DK37787D0 (da) 2,3-dioxabicyclooe3,3,0aaoctan-derivater og deres anvendelse som laegemidler
DK278290A (da) Substituerede 6h-pyridooe4,3-baacarbazoler og deres anvendelse som laegemidler
NO894516L (no) Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.
DK120889A (da) 3-(2,3,4,5,6-pentafluorphenoxy)-8-azabicyclooe3.2.1aaoctaner, en fremgangsmaade til deres fremstilling og deres anvendelse som medikamenter
NO901892D0 (no) Fremgangsmaate for fremstilling av (2,1-c)(1,3)-benzodiazepiner og deres anvendelse som medikamenter.
NO884445L (no) Nye antracyklinderivater, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel.